Atlas Trials

Everolimus After (Chemo)Embolization for Liver Metastases From Digestive Endocrine Tumors

Clinical trial NCT01678664 · COMPLETED

Trial details

NCT number
NCT01678664
Sponsor
Federation Francophone de Cancerologie Digestive
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Neuroendocrine TumorsHepatic MetastasesMetastases
Start date
2012-12-01
Primary completion
2018-09-01
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.